Kumagai H - Search Results

1

Identification of TSC-22 as a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD.

Lu Y, Kitaura J, Oki T, Komeno Y, Ozaki K, Kiyono M, Kumagai H, Nakajima H, Nosaka T, Aburatani H, Kitamura T. Lu Y, et al. Among authors: kumagai h. Leukemia. 2007 Nov;21(11):2246-57. doi: 10.1038/sj.leu.2404883. Epub 2007 Aug 9. Leukemia. 2007. PMID: 17690703

2

Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation.

Ono R, Kumagai H, Nakajima H, Hishiya A, Taki T, Horikawa K, Takatsu K, Satoh T, Hayashi Y, Kitamura T, Nosaka T. Ono R, et al. Among authors: kumagai h. Leukemia. 2009 Dec;23(12):2197-209. doi: 10.1038/leu.2009.177. Epub 2009 Aug 27. Leukemia. 2009. PMID: 19710696

3

Identification of novel membrane and secreted proteins upregulated during adipocyte differentiation.

Tsuruga H, Kumagai H, Kojima T, Kitamura T. Tsuruga H, et al. Among authors: kumagai h. Biochem Biophys Res Commun. 2000 May 27;272(1):293-7. doi: 10.1006/bbrc.2000.2759. Biochem Biophys Res Commun. 2000. PMID: 10872842

4

STAT5 induces macrophage differentiation of M1 leukemia cells through activation of IL-6 production mediated by NF-kappaB p65.

Kawashima T, Murata K, Akira S, Tonozuka Y, Minoshima Y, Feng S, Kumagai H, Tsuruga H, Ikeda Y, Asano S, Nosaka T, Kitamura T. Kawashima T, et al. Among authors: kumagai h. J Immunol. 2001 Oct 1;167(7):3652-60. doi: 10.4049/jimmunol.167.7.3652. J Immunol. 2001. PMID: 11564778

5

A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro.

Sugiyama T, Kumagai H, Morikawa Y, Wada Y, Sugiyama A, Yasuda K, Yokoi N, Tamura S, Kojima T, Nosaka T, Senba E, Kimura S, Kadowaki T, Kodama T, Kitamura T. Sugiyama T, et al. Among authors: kumagai h. Biochemistry. 2000 Dec 26;39(51):15817-25. doi: 10.1021/bi001583s. Biochemistry. 2000. PMID: 11123907

6

Proteolytic activation of SREBPs during adipocyte differentiation.

Inoue J, Kumagai H, Terada T, Maeda M, Shimizu M, Sato R. Inoue J, et al. Among authors: kumagai h. Biochem Biophys Res Commun. 2001 May 25;283(5):1157-61. doi: 10.1006/bbrc.2001.4915. Biochem Biophys Res Commun. 2001. PMID: 11355894

7

Conductance and relaxations of gelatin films in glassy and rubbery states.

Iwamoto S, Kumagai H, Hayashi Y, Miyawaki O. Iwamoto S, et al. Among authors: kumagai h. Int J Biol Macromol. 1999 Dec 15;26(5):345-51. doi: 10.1016/s0141-8130(99)00105-1. Int J Biol Macromol. 1999. PMID: 10628536

8

Spsgt1, a new essential gene of Schizosaccharomyces pombe, is involved in carbohydrate metabolism.

Kainou T, Shinzato T, Sasaki K, Mitsui Y, Giga-Hama Y, Kumagai H, Uemura H. Kainou T, et al. Among authors: kumagai h. Yeast. 2006 Jan 15;23(1):35-53. doi: 10.1002/yea.1336. Yeast. 2006. PMID: 16408318

9

Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study.

Kumagai H, Hayashi K, Kumamaru H, Saruta T. Kumagai H, et al. Am J Hypertens. 2000 Sep;13(9):980-5. doi: 10.1016/s0895-7061(00)00287-9. Am J Hypertens. 2000. PMID: 10981547 Clinical Trial.

10

Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.

Homma K, Hayashi K, Kanda T, Yoshioka K, Takamatsu I, Tatematsu S, Kumagai H, Wakino S, Saruta T. Homma K, et al. Among authors: kumagai h. J Hum Hypertens. 2004 Dec;18(12):879-84. doi: 10.1038/sj.jhh.1001761. J Hum Hypertens. 2004. PMID: 15295613 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,258 results

Search Page

Filters